These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 16326716)
1. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. Khalil IA; Kogure K; Futaki S; Harashima H J Biol Chem; 2006 Feb; 281(6):3544-51. PubMed ID: 16326716 [TBL] [Abstract][Full Text] [Related]
2. Intracellular fate of octaarginine-modified liposomes in polarized MDCK cells. Fujiwara T; Akita H; Harashima H Int J Pharm; 2010 Feb; 386(1-2):122-30. PubMed ID: 19922779 [TBL] [Abstract][Full Text] [Related]
3. Octaarginine- and octalysine-modified nanoparticles have different modes of endosomal escape. El-Sayed A; Khalil IA; Kogure K; Futaki S; Harashima H J Biol Chem; 2008 Aug; 283(34):23450-61. PubMed ID: 18550548 [TBL] [Abstract][Full Text] [Related]
4. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes. Nakamura T; Moriguchi R; Kogure K; Shastri N; Harashima H Mol Ther; 2008 Aug; 16(8):1507-14. PubMed ID: 18560420 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells. Yamada Y; Hashida M; Harashima H Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425 [TBL] [Abstract][Full Text] [Related]
6. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway. Mudhakir D; Akita H; Tan E; Harashima H J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812 [TBL] [Abstract][Full Text] [Related]
8. Particle tracking of intracellular trafficking of octaarginine-modified liposomes: a comparative study with adenovirus. Akita H; Enoto K; Masuda T; Mizuguchi H; Tani T; Harashima H Mol Ther; 2010 May; 18(5):955-64. PubMed ID: 20216528 [TBL] [Abstract][Full Text] [Related]
9. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357 [TBL] [Abstract][Full Text] [Related]
10. Octaarginine-modified liposomes enhance cross-presentation by promoting the C-terminal trimming of antigen peptide. Nakamura T; Ono K; Suzuki Y; Moriguchi R; Kogure K; Harashima H Mol Pharm; 2014 Aug; 11(8):2787-95. PubMed ID: 24901376 [TBL] [Abstract][Full Text] [Related]
11. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape. El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073 [TBL] [Abstract][Full Text] [Related]
12. Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery. Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H J Control Release; 2011 Jul; 153(2):141-8. PubMed ID: 21447361 [TBL] [Abstract][Full Text] [Related]
13. Cellular uptake and subsequent intracellular trafficking of R8-liposomes introduced at low temperature. Iwasa A; Akita H; Khalil I; Kogure K; Futaki S; Harashima H Biochim Biophys Acta; 2006 Jun; 1758(6):713-20. PubMed ID: 16780792 [TBL] [Abstract][Full Text] [Related]
14. Quantitative three-dimensional analysis of the intracellular trafficking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Akita H; Ito R; Khalil IA; Futaki S; Harashima H Mol Ther; 2004 Mar; 9(3):443-51. PubMed ID: 15006612 [TBL] [Abstract][Full Text] [Related]
15. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Nakase I; Niwa M; Takeuchi T; Sonomura K; Kawabata N; Koike Y; Takehashi M; Tanaka S; Ueda K; Simpson JC; Jones AT; Sugiura Y; Futaki S Mol Ther; 2004 Dec; 10(6):1011-22. PubMed ID: 15564133 [TBL] [Abstract][Full Text] [Related]
16. Octaarginine-modified liposomes enhance the anti-oxidant effect of Lecithinized superoxide dismutase by increasing its cellular uptake. Furukawa R; Yamada Y; Takenaga M; Igarashi R; Harashima H Biochem Biophys Res Commun; 2011 Jan; 404(3):796-801. PubMed ID: 21168389 [TBL] [Abstract][Full Text] [Related]
17. Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibition. Koshkaryev A; Piroyan A; Torchilin VP Cancer Lett; 2013 Jul; 334(2):293-301. PubMed ID: 22743614 [TBL] [Abstract][Full Text] [Related]
18. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery. Khalil IA; Hayashi Y; Mizuno R; Harashima H J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice. Mudhakir D; Akita H; Khalil IA; Futaki S; Harashima H Drug Metab Pharmacokinet; 2005 Aug; 20(4):275-81. PubMed ID: 16141607 [TBL] [Abstract][Full Text] [Related]